The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Selfotel in Acute Ischemic Stroke: Possible Neurotoxic Effects of an NMDA Antagonist
Open accessAbstract
Background and Purpose —Based on neuroprotective efficacy in animal models, we evaluated the N -methyl d -aspartate antagonist Selfotel in patients with ischemic stroke, after doses up to 1.5 mg/kg were shown to be safe in phase 1 and phase 2a studies. Methods —Two pivotal phase 3 ischemic stroke trials tested the hypothesis, by double-blind, randomized, placebo-controlled parallel design, that a single intravenous 1.5 mg/kg dose of Selfotel, administered within 6 hours of stroke onset, would improve functional outcome at 90 days, defined as the proportion of patients achieving a Barthel Index score of ≥60. The trials were performed in patients aged 40 to 85 years with acute ischemic hemispheric stroke and a motor deficit. Results —The 2 trials were suspended on advice of the independent Data Safety Monitoring Board because of an imbalance in mortality after a total enrollment of 567 patients. The groups were well matched for initial stroke severity and time from stroke onset to therapy. There was no difference in the 90-day mortality rate, with 62 deaths (22%) in the Selfotel group and 49 (17%) in the placebo-treated group (RR=1.3; 95% CI 0.92 to 1.83; P =0.15). However, early mortality was higher in the Selfotel-treated patients (day 30: 54 of 280 versus 37 of 286; P =0.05). In patients with severe stroke, mortality imbalance was significant throughout the trial ( P =0.05). Conclusions —Selfotel was not an effective treatment for acute ischemic stroke. Furthermore, a trend toward increased mortality, particularly within the first 30 days and in patients with severe stroke, suggests that the drug might have a neurotoxic effect in brain ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional evaluation : Barthel index
Mahonery, F. I. (1965) · Medical Entomology and Zoology · Cited by 12,762
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
Viability thresholds and the penumbra of focal ischemia
Hossmann, K. (1994) · Annals of Neurology · doi:10.1002/ana.410360404 · Cited by 1,370
Mahoney, F. I., & Barthel, D. W. (2013) · PsycTESTS Dataset · doi:10.1037/t02366-000 · Cited by 887
Grotta, J., Clark, W., Coull, B., Pettigrew, L. C., Mackay, B., Goldstein, L. B., Meissner, I., Murphy, D., & LaRue, L. (1995) · Stroke · doi:10.1161/01.str.26.4.602 · Cited by 208
Albers, G. W., Atkinson, R. P., Kelley, R. E., & Rosenbaum, D. M. (1995) · Stroke · doi:10.1161/01.str.26.2.254 · Cited by 195
Self-citationTermination of Acute Stroke Studies Involving Selfotel Treatment
Davis, S. M., Albers, G. W., Diener, H.-C., Lees, E. R., & Norris, J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62166-6 · Cited by 192
Self-citationCerestat and other NMDA antagonists in ischemic stroke
Lees, K. R. (1997) · Neurology · doi:10.1212/wnl.49.5_suppl_4.s66 · Cited by 184
Self-citation
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Adams, H. P., Adams, R. J., Brott, T., del Zoppo, G. J., Furlan, A., Goldstein, L. B., Grubb, R. L., Higashida, R., Kidwell, C., Kwiatkowski, T. G., et al. (2003) · Stroke · doi:10.1161/01.str.0000064841.47697.22 · Cited by 1,245
Glutamate receptors, neurotoxicity and neurodegeneration
Lau, A., & Tymianski, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0809-1 · Cited by 1,185
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181486 · Cited by 904
Brain ischemia and reperfusion: molecular mechanisms of neuronal injury
White, B. C., Sullivan, J. M., DeGracia, D. J., O’Neil, B. J., Neumar, R. W., Grossman, L. I., Rafols, J. A., & Krause, G. S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00386-5 · Cited by 796
Neuroprotection for ischemic stroke: Past, present and future
Ginsberg, M. D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.007 · Cited by 779
Calcium, ischemia and excitotoxicity
Szydlowska, K., & Tymianski, M. (2010) · Cell Calcium · doi:10.1016/j.ceca.2010.01.003 · Cited by 762
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
Ikonomidou, C., & Turski, L. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00164-3 · Cited by 721
Molecular pathophysiology of cerebral edema
Stokum, J. A., Gerzanich, V., & Simard, J. M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15617172 · Cited by 587
HYPOXIC-ISCHEMIC ENCEPHALOPATHY
Vannucci, R. (2000) · American Journal of Perinatology · doi:10.1055/s-2000-9293 · Cited by 524
Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:2:65 · Cited by 475
Pathogenesis of acute stroke and the role of inflammasomes
Fann, D. Y.-W., Lee, S.-Y., Manzanero, S., Chunduri, P., Sobey, C. G., & Arumugam, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.09.004 · Cited by 335
Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists
MUIR, K. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.12.002 · Cited by 312
Lees, K. R., Asplund, K., Carolei, A., Davis, S. M., Diener, H.-C., Kaste, M., Orgogozo, J.-M., & Whitehead, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02326-6 · Cited by 309
Self-citationCalcium ions in neuronal degeneration
Wojda, U., Salinska, E., & Kuznicki, J. (2008) · IUBMB Life · doi:10.1002/iub.91 · Cited by 301
Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
Savitz, S. I., & Fisher, M. (2007) · Annals of Neurology · doi:10.1002/ana.21127 · Cited by 267
Huang, J., Agus, D. B., Winfree, C. J., Kiss, S., Mack, W. J., McTaggart, R. A., Choudhri, T. F., Kim, L. J., Mocco, J., Pinsky, D. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171325998 · Cited by 225
The Optimising Analysis of Stroke Trials (OAST) Collaboration (2007) · Stroke · doi:10.1161/strokeaha.106.474080 · Cited by 192
Weaver, C. S., Leonardi-Bee, J., Bath-Hextall, F. J., & Bath, P. M. W. (2004) · Stroke · doi:10.1161/01.str.0000125010.70652.93 · Cited by 67
Should Stroke Trials Adjust Functional Outcome for Baseline Prognostic Factors?
The Optimising the Analysis of Stroke Trials (OAST) Collaboration (2009) · Stroke · doi:10.1161/strokeaha.108.519207 · Cited by 64
Vranesic, I., Ofner, S., Flor, P. J., Bilbe, G., Bouhelal, R., Enz, A., Desrayaud, S., McAllister, K., Kuhn, R., & Gasparini, F. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.09.033 · Cited by 59
Ingram, R., Kang, H., Lightman, S., Jane, D. E., Bortolotto, Z. A., Collingridge, G. L., Lodge, D., & Volianskis, A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.008 · Cited by 36
Weir, C. J., Kaste, M., & Lees, K. R. (2004) · Stroke · doi:10.1161/01.str.0000136556.34438.b3 · Cited by 31
Self-citation
Metadata
- Authors
- Davis, S. M., Lees, K. R., Albers, G. W., Diener, H. C., Markabi, S., Karlsson, G., & Norris, J.
- Venue
- Stroke
- Published
- 2000-02
- Volume
- 31
- Issue
- 2
- Pages
- 347-354
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1974898218
- Cited by
- 335
- References
- 20
- FWCI
- 14.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.